GSK plc GSK
NYSE GSK
$50.32 -0.09 (-0.18%)
At close: Nov 6, 2026 · 4:00 PM EST

Gsk (GSK) Non Operating Interest Expenses (2009 - 2026)

Updated

Gsk (GSK) reported Non Operating Interest Expenses of -$294.23 million for the quarter ended Sep 30, 2026, compared with -$225.34 million a year earlier.

Analysis

Gsk (GSK) Non Operating Interest Expenses (2009 - 2026) Analysis & Trends

Over the twelve months ended Sep 30, 2026, Gsk's Non Operating Interest Expenses came in at -$1.7 billion; for the year ended Dec 31, 2025, it came in at $924.28 million, up 8.1% from the prior year.

  • Non Operating Interest Expenses has a five-year compound annual growth rate of -3.8% (years ended Dec 2020 to Dec 2025).
  • By year, Non Operating Interest Expenses came in at $855.17 million in the year ended Dec 31, 2024 (-13.2%), $985.11 million in the year ended Dec 31, 2023 (-9.4%), $1.09 billion in the year ended Dec 31, 2022 (+2.8%) and $1.06 billion in the year ended Dec 31, 2021 (-5.7%).
  • Five-year quarterly Non Operating Interest Expenses spans a low of -$1.03 billion in the quarter ended Dec 31, 2022 and a high of -$202.69 million in the quarter ended Sep 30, 2024.
  • Per Business Quant data, the three quarters before the quarter ended Sep 30, 2026 came in at -$244.19 million (quarter ended Jun 30, 2026), -$225.15 million (quarter ended Mar 31, 2026) and -$932.45 million (quarter ended Dec 31, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Interest Expenses (Qtr)
1 Eli Lilly 1,224.11 Bn 1,197.72 Bn 20.46 Bn -
2 Johnson & Johnson 665.34 Bn 585.20 Bn 17.30 Bn 217.00 Mn
3 AbbVie 515.72 Bn 483.73 Bn 13.12 Bn -
4 Merck 362.64 Bn 325.58 Bn 13.19 Bn -
5 Novartis Ag 315.51 Bn 288.75 Bn - -
6 Astrazeneca 289.26 Bn 263.15 Bn 13.26 Bn -477.00 Mn
7 Amgen 249.20 Bn 200.85 Bn 7.58 Bn 653.00 Mn
8 Gilead Sciences 207.48 Bn 182.59 Bn 6.73 Bn 269.00 Mn
9 Pfizer 167.49 Bn 114.85 Bn 12.56 Bn -
10 Gsk 102.08 Bn 84.92 Bn 8.73 Bn -294.23 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -294.23 Mn
Jun 30, 2026 -244.19 Mn
Mar 31, 2026 -225.15 Mn
Dec 31, 2025 -932.45 Mn
Sep 30, 2025 -225.34 Mn
Jun 30, 2025 -245.46 Mn
Mar 31, 2025 -204.04 Mn
Dec 31, 2024 -858.66 Mn
Sep 30, 2024 -202.69 Mn
Jun 30, 2024 -219.63 Mn
Mar 31, 2024 -210.57 Mn
Dec 31, 2023 -982.99 Mn
Sep 30, 2023 -230.54 Mn
Jun 30, 2023 -231.50 Mn
Mar 31, 2023 -246.75 Mn
Dec 31, 2022 -1.03 Bn
Sep 30, 2022 -235.71 Mn
Jun 30, 2022 -256.90 Mn
Mar 31, 2022 -275.08 Mn
Dec 31, 2021 -253.43 Mn
API Access

Gsk Non Operating Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=GSK&period=max&api_key=YOUR_API_KEY